الولايات المتحدة · منصات وبيانات · MarketBeat

Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

نشره MarketBeat · الولايات المتحدة منذ 1 س

Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional…

اقرأ المقال كاملًا على MarketBeat سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)

يستحق القراءة أيضًا

The Motley Fool

Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching.

MarketWatch

The Social Security Administration wants more babies signed up for ‘Trump accounts.’ But there’s still a catch.

Investing.com

Bank of Korea holds rates, upbeat outlook points to future hikes

Stocktwits

FUN Stock Heads For 4th Week Of Loss: Analyst Sees 29% Downside Ahead Of Earnings As Mounting Debt, Weak Sales Loom

TheStreet

KFC rolls out 13 days of Halloween deals, but there’s a catch

CNBC